HCA Healthcare Officer Files Form 144 to Sell $5.63M in Common Stock
HCA Healthcare, Inc.
Subscribe to track HCA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Notice of Proposed Sale of Securities Issuer: HCA Healthcare, Inc. (HCA) Insider: Michael S Cuffe (Officer) Shares to Sell: 11,800 Estimated Total Value: $5,628,600 Approx. Sale Date: 10/29/2026 Broker: Merrill Lynch
Comprehensive Analysis
Executive Summary
On October 29, 2026, Michael S Cuffe, an Officer of HCA Healthcare, Inc. (CIK: 0000860730), filed a Form 144 notice disclosing the proposed sale of 11,800 shares of common stock with an aggregate market value of approximately $5.63 million.
Transaction Breakdown
- Securities Class: Common Stock
- Number of Units: 11,800 shares
- Aggregate Market Value: $5,628,600 (approx. $477.00 per share)
- Approximate Sale Date: October 29, 2026
- Executing Broker: Merrill Lynch
Origin of Securities
The shares proposed to be sold were acquired via equity compensation awards:
- 1,747 shares acquired on February 13, 2025, via Performance Award Vest.
- 6,127 shares acquired on February 10, 2026, via Performance Award Vest.
- 3,926 shares acquired on October 29, 2026, via the exercise of Stock Appreciation Rights.
Impact and Context
The proposed sale represents a fraction of HCA Healthcare's 216,501,500 outstanding common shares. Given the origin in performance vesting and stock appreciation rights, this transaction appears to be standard compensatory monetization.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.